NPM1 and acute myeloid leukemia: Among detection techniques, IHC is almost inexpensive in the diagnostic-prognostic work-up of AML patients with normal karyotypes, and recently, IHC has been used to detect cytoplasmic NPM1 as a surrogate for NPM1 mutations involving exon 12 or other uncommon sites18.